Browsing School of Medicine by Author "Jayne, David"

Now showing items 1-3 of 3

    • Comparisons of Guidelines and Recommendations on Managing Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. 

      Little, Mark; Geetha, Duvuru; Jin, Quiyu; Scott, Jennifer; Hruskova, Zdenka; Hanouneh, Mohamad; Tesar, Vladimir; Seo, Philip; Jayne, David; Pagnoux, Christian (2018)
      Antineutrophil cytoplasmic antibodies−associated vasculitis (AAV) is associated with high morbidity or mortality, especially if not promptly diagnosed and treated. Many inroads have been made in the understanding of the ...

    • Efficacy and Safety of Belimumab and Azathioprine for Maintenance of Remission in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: A Randomized Controlled Study 

      Little, Mark; Jayne, David; Blockmans, Daniel; Luqmani, Raashid; Moiseev, Sergey; Ji, Beulah; Green, Yulia; Hall, Leanne; Roth, David; Henderson, Robert B.; Merkel, Peter A. (2019)
      Objective: To evaluate the safety and efficacy of belimumab as adjunctive therapy to maintain remission in antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV). Methods: In this multicenter, ...

    • The European Vasculitis Society 2016 Meeting Report 

      LITTLE, MARK; Bajema, Ingeborg M.; Bruijn, Jan A.; Casian, Alina; Cid, Maria C.; Csernok, Elena; van Daalen, Emma; Harper, Lorraine; Hauser, Thomas; Luqmani, Raashid; Mahr, Alfred; Ponte, Cristina; Salama, Alan; Segelmark, Mårten; Suzuki, Kazuo; Sznajd, Jan; Teng, Y.K. Onno; Vaglio, Augusto; Westman, Kerstin; Jayne, David (2017)
      The 2016 European Vasculitis Society (EUVAS) meeting, held in Leiden, the Netherlands, was centered around phenotypic subtyping in antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV). There were parallel ...